(Q48925750)

2 July 2019

title

Atp13a2 Deficiency Aggravates Astrocyte-Mediated Neuroinflammation via NLRP3 Inflammasome Activation. (English)

1 reference

2 July 2019

0 references

0 references

1 reference

Chen Qiao

1

1 reference

2 July 2019

Nuo Yin

2

1 reference

2 July 2019

Huan-Yu Gu

3

1 reference

2 July 2019

Jia-Lei Zhu

4

1 reference

2 July 2019

Jian-Hua Ding

5

1 reference

2 July 2019

Ming Lu

6

1 reference

2 July 2019

Gang Hu

7

1 reference

2 July 2019

publication date

5 February 2016

1 reference

2 July 2019

CNS Neuroscience & Therapeutics

published in

1 reference

2 July 2019

volume

22

1 reference

2 July 2019

issue

6

1 reference

2 July 2019

page(s)

451-460

1 reference

2 July 2019

Neuroinflammation in Parkinson's disease and its potential as therapeutic target

cites work

1 reference

Imaging brain networks in neurodegenerative diseases.

21 January 2018

1 reference

Resting-state functional brain networks in Parkinson's disease.

21 January 2018

1 reference

α-Synuclein aggregation and modulating factors

21 January 2018

1 reference

The cell biology of disease: lysosomal storage disorders: the cellular impact of lysosomal dysfunction

21 January 2018

1 reference

Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies

21 January 2018

1 reference

Pathogenic lysosomal depletion in Parkinson's disease

21 January 2018

1 reference

Alterations in lysosomal and proteasomal markers in Parkinson's disease: relationship to alpha-synuclein inclusions.

21 January 2018

1 reference

Analysis of LRRK2 accessory repeat domains: prediction of repeat length, number and sites of Parkinson's disease mutations

21 January 2018

1 reference

A lipid switch unlocks Parkinson's disease-associated ATP13A2

21 January 2018

1 reference

Inflammasomes in neuroinflammation and changes in brain function: a focused review

21 January 2018

1 reference

Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe/PS1dE9 transgenic mice via inhibition of nuclear factor-κB and NLRP3 inflammasome activation

21 January 2018

1 reference

Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome

21 January 2018

1 reference

Astrocyte development and heterogeneity

21 January 2018

1 reference

Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease.

21 January 2018

1 reference

Prevention of the degeneration of human dopaminergic neurons in an astrocyte co-culture system allowing endogenous drug metabolism

21 January 2018

1 reference

Uncoupling protein 2 deficiency aggravates astrocytic endoplasmic reticulum stress and nod-like receptor protein 3 inflammasome activation

21 January 2018

1 reference

Parkinson's disease-associated human P5B-ATPase ATP13A2 increases spermidine uptake

21 January 2018

1 reference

Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

21 January 2018

1 reference

Deficiency of ATP13A2 leads to lysosomal dysfunction, α-synuclein accumulation, and neurotoxicity

21 January 2018

1 reference

Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein

21 January 2018

1 reference

K(ATP) channel openers protect mesencephalic neurons against MPP+-induced cytotoxicity via inhibition of ROS production

21 January 2018

1 reference

The Pro-inflammatory Cytokine Interleukin-1β is a Key Regulatory Factor for the Postictal Suppression in Mice.

21 January 2018

1 reference

Therapeutics targeting the inflammasome after central nervous system injury

21 January 2018

1 reference

Cathepsin B contributes to autophagy-related 7 (Atg7)-induced nod-like receptor 3 (NLRP3)-dependent proinflammatory response and aggravates lipotoxicity in rat insulinoma cell line

21 January 2018

1 reference

Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth

21 January 2018

1 reference

Neuron-glia networks: integral gear of brain function.

21 January 2018

1 reference

Astrocytes: more than just glue.

21 January 2018

1 reference

Glia: initiators and progressors of pathology in Parkinson's disease

21 January 2018

1 reference

Mechanisms and potential therapeutic applications of microglial activation after brain injury

21 January 2018

1 reference

Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease

21 January 2018

1 reference

Cysteine cathepsins and extracellular matrix degradation.

21 January 2018

1 reference

The 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model: a tool to explore the pathogenesis of Parkinson's disease

21 January 2018

1 reference

12 December 2020

Inflammation in Parkinson's disease

1 reference

12 December 2020

New insights into lysosomal dysfunction in Parkinson’s disease: an emerging role for ATP13A2

1 reference

12 December 2020

Inhibition of cysteine cathepsin B and L activation in astrocytes contributes to neuroprotection against cerebral ischemia via blocking the tBid-mitochondrial apoptotic signaling pathway

1 reference

12 December 2020

Knockdown of interleukin-1 receptor 1 is not neuroprotective in the 6-hydroxydopamine striatal lesion rat model of Parkinson's disease

1 reference

12 December 2020

Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous α-synuclein fibrils

1 reference

12 December 2020

The ubiquitin proteasome system as a potential therapeutic target for treatment of neurodegenerative diseases

1 reference

12 December 2020

[Oxidative stress and Parkinson's disease: mechanisms and perspectives of treatment]

1 reference

12 December 2020

Identifiers

DOI

10.1111/CNS.12514

1 reference

2 July 2019

PMCID

6492810

1 reference

2 July 2019

PubMed ID

26848562

1 reference

2 July 2019